Scholars Central

Conference abstractPublished 26 Feb 2018

Designing and evaluating of oral nanoparticle dutasteride tablet dosage form

Authors: Mozhdeh Hemati, Fereshteh Bagheri, Reza Tahvilian

Kermanshah University of Medical Sciences, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dutasteride is a potential and selective inhibitor of both types of 5Ã?±-reductase enzyme which converts testosterone to dihydrotestosterone. Therefore, the treatment of Benign Prostatic Hyperplasia (BPH) is performed by inhibiting 5Ã?±-reductase. Dutasteride indications are BPH and men's alopecia and marketed as a capsule dosage form. In many aspects, nano tablets have significant advantages to capsules, for instance in the specificity, dosage release, efficacy and side effects. Moreover, nano drug delivery method is effective, controlled and targeted. The purpose of this study is to prepare new tablet formulation containing dutasteride nanoparticles to improve the Intestinal absorption. This system was prepared by Eudragit RP40 and dutasteride dissolved into ethanol, tween 80, benzalkonium chloride, and distilled water. The mean particle size and zeta potential were determined using Photon Correlation Spectroscopy (PCS) using a Malvern Zeta sizer. The dutasterideloaded Eudragit nanoparticles with a mean particle size nearly 155 nm and PdI 0.136 were prepared by simple and fast method. Then the nano dutasteride formulated as a tablet dosage form. The drug release and other physico- chemical control tests were assessed. The obtained results revealed that nano tablet dosage form is more suitable as compared to capsule and tablet ones. Recent Publications: 1. Kamila M M, Mondal N, Ghosh L K (2010) A validated spectrophotometric method for determination of dutasteride in bulk drug and pharmaceutical formulations. Intl. J. of Pharma Tech. 2(1):113-117. 2. Choi Y H, Cho S Y, Cho I R (2010) The different reduction rate of prostate-specific antigen in dutasteride and finasteride. Korean J. Urol. 51(10):704-708. 3. Xie X, Yang Y, Chi Q, Li Z, Zhang H et al. Controlled release of dutasteride from biodegradable microspheres: in vitro and in vivo studies. PloS one. 9(12):e114835. 4. Min Soo Kim (2013) Influence of hydrophilic additives on the supersaturation and bioavailability of dutasterideloaded hydroxypropyl-Ã?²-cyclodextrin nanostructures. Int. J. of Nanomedicine. 8:2029-2039. 5. Dong Hoon Lee, Dong Woo Yeom, Ye Seul Song, Ha Ra Cho, Yong Seok Choi, Myung Joo Kang, Young Wook Choi (2015) Improved oral absorption of dutasteride via SoluplusÃ?®-based supersaturable self-emulsifying drug delivery system (S-SEDDS). 478(1):341-347.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmacoeconomics: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmacoeconomics: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Mozhdeh Hemati”
  • BylineArticles whose byline prints “Fereshteh Bagheri”
  • BylineArticles whose byline prints “Reza Tahvilian”